Gut microbiome features associate with immune checkpoint inhibitor response in individuals with non-melanoma skin cancers: an exploratory study

ABSTRACT Immune checkpoint inhibitor (ICI) therapy has yielded revolutionary outcomes among some individuals with skin cancer, but a large percentage of individuals do not benefit from these treatments. The gut microbiota is hypothesized to impact ICI therapy outcomes. However, data on ICI therapy,...

Full description

Saved in:
Bibliographic Details
Main Authors: Yujie Zhao, Jacqueline T. Ferri, James R. White, Megan D. Schollenberger, Kim Peloza, Cynthia L. Sears, Evan J. Lipson, Fyza Y. Shaikh
Format: Article
Language:English
Published: American Society for Microbiology 2025-03-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02559-24
Tags: Add Tag
No Tags, Be the first to tag this record!